
北米サルコペニア治療市場予測 2030年 - 地域分析 - 治療タイプ別(ビタミンDおよびカルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメントなど)および流通チャネル別(薬局、小売チャネル、オンラインチャネルなど)
No. of Pages: 72 | Report Code: BMIRE00030523 | Category: Life Sciences
No. of Pages: 72 | Report Code: BMIRE00030523 | Category: Life Sciences
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
10. Makers Nutrition LLC
The North America Sarcopenia Treatment Market is valued at US$ 1,451.12 Million in 2022, it is projected to reach US$ 2,273.85 Million by 2030.
As per our report North America Sarcopenia Treatment Market, the market size is valued at US$ 1,451.12 Million in 2022, projecting it to reach US$ 2,273.85 Million by 2030. This translates to a CAGR of approximately 5.8% during the forecast period.
The North America Sarcopenia Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Sarcopenia Treatment Market report:
The North America Sarcopenia Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Sarcopenia Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Sarcopenia Treatment Market value chain can benefit from the information contained in a comprehensive market report.